Explore more than 1.3 million company profiles from emerging markets

Sunzen Biotech Berhad (Malaysia)

Main Activities: Research and Development in Biotechnology
Quote Chart
Quote Summary
Last Price 0.5100
Volume 1,784,600
Turnover 927,992
Index
Market EXCH
Ticker 148
Market Cap Market Cap 76,194
52 Week High 0.5900
52 Week Low 0.2050
P/E
EPS
Dividend Yield
Bookvalue
Enterprise Value
Quote updated on January 26, 2015
Note: data in MYR Thousands.
Financials
Select Items to chart them. 2014 Q2C
Net sales revenue
Total Operating Revenue
Operating profit (EBIT)
EBITDA
Net Profit(Loss)
Total Assets 43,492
Total equity
Operating Profit Margin
Return on Sales (ROS)
Return on Equity (ROE)
Debt to equity
Quick ratio
Cash Ratio
Note: units in Thousands. Statement: Non-Audited, Consolidated
Source: World's Vest Base, EMIS Company Database.
Company Description

Sunzen Biotech Berhad engages in the biotechnology research and production of animal health products (feed supplement). The principal activities of the subsidiaries are R&D and commercialisation of in-feed anti bacterial products and supplements for animal health products, the distribution and marketing of animal health products. The group consists of Sunzen Biotech and wholly owned subsidiaries namely Sunzen Corporation, Sunzen LifeSciences and Sunzen Feedtech. The Company was incorporated in 2005 and is…

More
Contact Information

Legal Address
10th Floor, Menara Hap Seng,No. 1 & 3, Jalan P. Ramlee, City
Kuala Lumpur; Federal Territories; Map
Postal Code: 50250
Tel: +60-3-2382-4288
Fax: +60-3-2382-4170
Email: admin@sunzenbio.com
Website: http://www.sunzen.com.my

Full name: Sunzen Biotech Berhad

Status: Listed
Legal Form: Public Limited Company
Operational Status: Operational
Incorporation Date: 2005

Basic Information
Outstanding Shares:
: ()
Financial Auditors:
()
Key Executives
Ownership Details
KIM SING TAN
27.5%
Other
Affiliates and related companies
Sunzen Corporation Sdn. Bhd.
100%
Corporate Actions
EMIS Benchmark Score
EMIS DealWatch Deals
DealMonitor Deal Intents
EMIS DealWatch News
Financial Documents/Annual Reports
Competitors - Malaysia
MYR | USD | EUR
Analysis/Research

Receive our Global EMIS Insider

The Global EMIS Insider is a our monthly source of Emerging Markets Information Service (EMIS) functionality enhancements and new content releases in each of our countries worldwide.
First Name: *
Country: *
Last Name: * Company: *
Email: * Position: *
Security Code: *   * Indicates required field.

USE OF YOUR INFORMATION:
EMIS is part of the Euromoney Institutional Investor PLC group of companies. Click here for more details on our group's activities.
We will use the information you provide here to process your order/registration/request including communicating with you about it. If you are registering for a trial, you will receive a follow up email and/or call asking you about your trial. As part of the trial, you may also receive email updates and other features as specified for that product. We may monitor your use of our website(s). As an international group, we may transfer your data on a global basis. Subject to your choices below, we may also use your data for marketing purposes. By submitting your details, you will be indicating your consent to the use of your data as identified here. Further information is set out in our privacy policy on this site.

Please tick if you don't want to receive details of products, services and special offers from our group companies by:

Phone    Fax    Email    Mail

Please tick if you don't want to receive details of relevant products, services and special offers from selected companies outside our group

I have read and agree to the Terms and Conditions.

I have read and agree to the Privacy Policy.